Production (Stage)
SpringWorks Therapeutics, Inc.
SWTX
$46.68
$0.220.47%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.62% | -44.40% | -34.10% | 54.32% | 7.35% |
| Total Depreciation and Amortization | 8.26% | 15.83% | 4.03% | 15.78% | 35.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.81% | -1.16% | -0.04% | -10.73% | 16.47% |
| Change in Net Operating Assets | -227.24% | 1,682.53% | 96.22% | -29.05% | -753.00% |
| Cash from Operations | -133.08% | -16.24% | 39.27% | 47.05% | -25.88% |
| Capital Expenditure | 97.15% | 43.04% | -89.44% | -68.98% | -125.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 383.14% | -50.17% | 2,312.58% | -94.26% | 113.65% |
| Cash from Investing | 418.86% | -50.62% | 9,812.80% | -98.65% | 113.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 92.18% | -34.30% | -58.28% | -27.84% | -98.01% |
| Repurchase of Common Stock | -2,360.61% | -4.81% | 45.70% | 85.86% | -2,467.98% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,724.66% | -49.42% | -61.70% | 710.69% | -100.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.36% | -422.41% | 111.96% | 34.28% | -175.19% |